VYOME HOLDINGS, INC. Retained Earnings
VYOME HOLDINGS, INC. (HIND) had Retained Earnings of -$89.21 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$89.21M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$88.53M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$87.56M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$86.34M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$89.21M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$88.53M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | -$87.56M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$86.34M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$56.03M 8-K · filed 2025-09-02 | -$643.86M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$641.23M 10-Q · filed 2025-05-20 | |
| 2024-12-31 | -$55.42M 10-K · filed 2026-03-18 | -$642.70M 10-K · filed 2025-04-04 |
| 2024-09-30 | -$640.94M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$639.36M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$637.77M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$635.57M 10-K · filed 2025-04-04 | |
| 2023-09-30 | -$633.88M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$630.34M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | -$626.85M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$624.19M 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$607.72M 10-K · filed 2023-04-17 | -$606.36M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$595.53M 10-K · filed 2023-04-17 | -$594.55M 10-Q · filed 2022-08-19 |
| 2022-03-31 | -$586.09M 10-K · filed 2023-04-17 | |
| 2021-12-31 | -$577.97M 10-K · filed 2023-04-17 | -$576.76M 10-K · filed 2022-04-08 |
| 2021-09-30 | -$540.72M 10-K · filed 2023-04-17 | -$541.30M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$523.59M 10-K · filed 2023-04-17 | -$523.60M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$188.93M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | -$514.83M 10-K · filed 2022-04-08 | -$184.76M 10-K · filed 2021-03-12 |
| 2020-09-30 | -$183.44M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | -$181.88M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | -$177.69M 10-Q · filed 2020-06-19 | |
| 2019-12-31 | -$172.43M 10-K · filed 2021-03-12 | |
| 2019-09-30 | -$167.52M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | -$163.81M 10-Q · filed 2019-07-24 | |
| 2019-03-31 | -$157.04M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | -$148.75M 10-K · filed 2020-02-27 | |
| 2018-09-30 | -$140.00M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | -$133.25M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | -$123.50M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$111.37M 10-K · filed 2019-02-22 | |
| 2017-09-30 | -$101.25M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | -$92.08M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | -$84.35M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$76.61M 10-K · filed 2018-03-05 | |
| 2016-09-30 | -$69.11M 10-Q · filed 2016-11-10 | |
| 2015-12-31 | -$56.14M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |